AmerisourceBergen’s Lash Group unveils Fusion to power patient support
FORT MILL, S.C. — AmerisourceBergen’s Lash Group this week unveiled Fusion, a new tech ecosystem for patient support. Fusion is designed to go beyond being a customer relationship management platform, bringing together technologies with workflows customized for patients support services, and offering a proprietary advanced data model that lets the Lash Group provide patients, providers and manufacturers a personalized experience, the company said.
“Pharmaceutical manufacturers face a growing array of new challenges in the market. Intense competition, rising commercialization costs, disaggregated data, consumerism and a shift to value-based care are key issues that complicate the commercialization process,” AmerisourceBergen group president global commercialization services and animal health Jim Cleary said. “Fusion enables Lash Group to provide greater support to manufacturers, while also increasing efficiency and providing a more comprehensive set of services throughout the patient journey and product lifecycle.”
Fusion was developed to streamline administrative tasks through to speed access to treatment, using artificial intelligence for benefit verification and leveraging multichannel communication capabilities to remove common barriers to therapy. Fusion also looks to create a simpler set of patient-provider interactions through such features as computer-telephony integration. And the platform can generate actionable insights for manufacturers through data management, real-time reports and dashboards, as well as targeted analytics, competitive intelligence and a more holistic view of the patient experience, the company said.
“There is no stronger example of AmerisourceBergen’s commitment to innovation and our ability to develop and deploy technologies that advance healthcare than Fusion,” AmerisourceBergen chief information officer Dale Danilewitz said. “By combining Lash Group’s high-tech, smart-touch service model with dozens of proven tools and the company's deep expertise across life sciences, we’re producing a seamless, end-to-end experience for manufacturers, providers and most importantly, patients.”
In wake of Harvey, Paramount Rx helps cover cost of tetanus vaccines at H-E-B stores
CARY, N.C. — In response to public health concerns associated with flooding, Prescription Benefits Manager Paramount Rx has partnered with grocery retailer H-E-B to support the distribution of 2,500 free tetanus vaccinations at H-E-B stores in certain areas affected by Hurricane Harvey.
“Even as flood waters recede, leftover debris still pose a threat to those who have not received a tetanus booster in the last 10 years,” reported Ken Hammond, president Paramount Rx. “As an organization dedicated to improving the health and wellbeing of our customers, we were grateful for the opportunity to collaborate with H-E-B to help protect Houston residents in the difficult months ahead.”
Paramount Rx donated $75,000 to support the distribution of tetanus vaccinations in the Houston and Gulf Coast region. Tetanus, often called lockjaw, is a serious infection caused by bacteria present in soil and dust. Coming into contact with flood debris could increase the likelihood of infection.
Synergy Medical ranks on Canadian Business’ 2017 Profit 500
MONTREAL, Canada — Synergy Medical is among Canada’s fastest-growing companies, according to the latest installation of the Canadian Business Profit 500. The ranking, published in the Maclean’s October issue and on CanadianBusiness.com, ranks 500 Canadian businesses based on their five-year revenue growth. Synergy Medical made the 2017 Profit 500 with five-year revenue growth of 78%.
“It is never easy to earn a spot on the Profit 500, but this year’s applicant pool was the most competitive yet,” Profit 500 program manager Deborah Aarts said. “This year’s winners demonstrate the resilience, innovation and sheer management smarts it takes to build a thriving business today.”
The company, which launched in 2008, designs, manufactures and installs pharmacy automation systems aimed at improving pharmacy efficiency while improving patient adherence. Synergy Medical has installed more than 300 of its SynMed and SynMed Ultra systems in North America and Europe.
“It is an honor for Synergy Medical to be classed among the fastest growing Canadian companies, and to be given the Profit 500 designation.” Synergy Medical president and founder Jean Boutin said. “It is the unwavering dedication and sustained efforts of our team that has allowed Synergy Medical to provide market-leading automation solutions to pharmacies, and consequently to receive this recognition.”